Regeneration of an infected skin wound under conditions of experimental steroid hyperglycemia

Purpose. To evaluate the regeneration of an infected skin wound in experimental steroid hyperglycemia in rats.

Materials and methods. Regeneration of an infected rat skin wound (n = 30) was evaluated on the background of steroid hyperglycemia. Depending on the type of wound surface treatment, all observed animals were divided into 3 groups: the first group (n = 10) was treated with an ointment containing Cymbopogon proximus per os administration; the second group (n = 10) was treated with an ointment containing sodium fusidate 2 %; the third group (n = 10, control) the wound was treated with vaseline. After five days, local changes in the wound area and the activity of its regeneration were evaluated. We also studied the blood changes: the composition of the shaped elements and the content of total protein, albumins, transaminase activity (ALT, AST), total cholesterol, urea and creatinine.

Results. The use of Cymbopogon proximus orally by rats of the first group, with induced diabetes mellitus, contributes to a decrease in serum glucose levels by almost two times compared with the second and third groups. Ointment containing Cymbopogon proximus has immunomodulatory properties: it prevents the development of leukopenia, promotes the activation of agranular immunocytes. The use of Cymbopogon proximus extract has a positive effect on the rate of wound regeneration due to several factors: reduction of hyperemia and edema, stimulation of leukocyte activity, and as a consequence activation of regeneration. We did not find a significant difference in the rate of wound regeneration when treated with an ointment based on Cymbopogon proximus extract and an ointment containing sodium fusidate (p > 0.05).

Conclusion. The regeneration activity of an infected wound in rats with steroid hyperglycemia does not significantly differ when treated with antimicrobial ointment and Cymbopogon proximus. The extract of Cymbopogon proximus has a double effect in vivo: it reduces glucose levels and promotes wound healing in the condition of hyperglycemia, which is promising in the treatment of complications in diabetes mellitus.

1. Protasova TP, Goncharova AS, Zhukova GV, Lukbanova EA, Tkachev SYu, Mindar MV. Problem of chronic pain in oncology and approaches to its relief. South Russian Journal of Cancer. 2020;1(1):32–42. (In Russ.). https://doi.org/10.37748/2687‑0533‑2020‑1‑1‑3

2. Nechayev VM, Damulin IV, Baranov SA, Shulpekova YuO, Baranskaya EK, Popova IR, et al. Abdominal pain related to pathology of peripheral nervous system. Medical News of North Caucasus. 2019;14(2):407–412. (In Russ.). https://doi.org/10.14300/mnnc.2019.14101

3. Kulchenko NG, Yacenko EV. The role of anti‑inflammatory therapy in the treatment of acute and chronic prostatitis. Features of innovative Ketoprofen molecule. Literature review. Experimental and Clinical Urology. 2019;(3):158–163. (In Russ.). https://doi.org/10.29188/2222‑8543‑2019‑11‑3‑158‑163

4. Nguyen VH, Goel AP, Yerra S, Hamill‑Ruth R. Use of a Screening Questionnaire to Identify Patients at Risk of Hyperglycemia Prior to Steroid Injection Therapy. Pain medicine. 2018;19(11): 2109–2114. https://doi.org/10.1093/pm/pnx209

5. Polderman JA, Farhang‑Razi V, Van Dieren S, Kranke P, DeVries JH, Hollmann MW, et al. Adverse side effects of dexamethasone in surgical patients. Cochrane Database Syst Rev. 2018 Nov 23;11(11):CD011940. https://doi.org/10.1002/14651858.cd011940.pub3

6. Suh S, Park MK. Glucocorticoid‑Induced Diabetes Mellitus: An Important but Overlooked Problem. Endocrinol Metab (Seoul). 2017 Jun;32(2):180–189. https://doi.org/10.3803/enm.2017.32.2.180

7. El‑Tantawy WH, Temraz A. Management of diabetes using herbal extracts: review. Arch Physiol Biochem. 2018 Dec;124(5):383–389. https://doi.org/10.1080/13813455.2017.1419493

8. Petrov VI, Vinarov AZ, Vekilyan MA, Kulchenko NG. Changes in the structure of pathogens of calculous pyelonephritis complicated with diabetes mellitus type ii, in the hospital urology of the city of Volgograd. Urologiia. 2016;4:58–62. (In Russ.).

9. Roitberg GE, Dorosh ZhV, Sharkhun OO. A new method for screening diagnosis of insulin resistance. Bull Exp Biol Med. 2015 Jan;158(3):397–400. https://doi.org/10.1007/s10517‑015‑2771‑6

10. Galstyan GR, Vikulova OK, Isakov MA, Zheleznyakova AV, Serkov AA, Egorova DN, et al. Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the federal diabetes register (2013–2016). Diabetes Mellitus. 2018;21(3):170–177. (In Russ.). https://doi.org/10.14341/dm9688

11. Bokeria LA, Arakelyan VS, Papitashvili VG, Tsurtsumiya ShSh. Limb revascularization in patients with diabetes mellitus. RUDN Journal of Medicine. 2019;23(4):349–363. (In Russ.). https://doi.org/10.22363/2313‑0245‑2019‑23‑4‑349‑363

12. Aralova MV, Atyakshin DA, Glukhov AA, Andreev AA, Chuyan AO, Karapityan AR. Mast cells as an active component of wound repair process. Journal of Anatomy and Histopathology. 2018;7(2):103–109. (In Russ.). https://doi.org/10.18499/2225‑7357‑2018‑7‑2‑103‑109

13. Ramirez‑Acuña JM, Cardenas‑Cadena SA, Marquez‑Salas PA, Garza‑Veloz I, Perez‑Favila A, Cid‑Baez MA, et al. Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments. Antibiotics (Basel). 2019 Oct 24;8(4):193. https://doi.org/10.3390/antibiotics8040193

14. Quave CL. Wound healing with botanicals: A review and future perspectives. Curr Dermatol Rep. 2018 Dec;7(4):287–295. https://doi.org/10.1007/s13671‑018‑0247‑4

15. Hawkins P, Morton DB, Burman O, Dennison N, Honess P, Jennings M, et al.; UK Joint Working Group on Refinement BVAAWF/ FRAME/RSPCA/UFAW. A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Lab Anim. 2011 Jan;45(1):1–13. https://doi.org/10.1258/la.2010.010031

16. Governa P, Baini G, Borgonetti V, Cettolin G, Giachetti D, Magnano AR, et al. Phytotherapy in the Management of Diabetes: A Review. Molecules. 2018 Jan 4;23(1):105. https://doi.org/10.3390/molecules23010105

17. Marmitt DJ, Shahrajabian MH, Goettert MI, Rempel C. Clinical trials with plants in diabetes mellitus therapy: a systematic review. Expert Rev Clin Pharmacol. 2021 Jun;14(6):735–747. https://doi.org/10.1080/17512433.2021.1917380

18. Ríos JL, Francini F, Schinella GR. Natural Products for the Treatment of Type 2 Diabetes Mellitus. Planta Med. 2015 Aug;81(12‑13):975–994. https://doi.org/10.1055/s‑0035‑1546131

19. Taj Eldin IM, Ahmed EM, Elwahab H M A. Preliminary Study of the Clinical Hypoglycemic Effects of Allium cepa (Red Onion) in Type 1 and Type 2 Diabetic Patients. Environ Health Insights. 2010 Oct 14;4:71–77. https://doi.org/10.4137/ehi.s5540

20. Liu C, Zhang M, Hu MY, Guo HF, Li J, Yu YL, et al. Increased glucagon‑like peptide‑1 secretion may be involved in antidiabetic effects of ginsenosides. J Endocrinol. 2013 Apr 15;217(2):185–196. https://doi.org/10.1530/joe‑12‑0502

21. Elbashir SMI, Devkota HP, Wada M, Kishimoto N, Moriuchi M, Shuto T, et al. Free radical scavenging, α‑glucosidase inhibitory and lipase inhibitory activities of eighteen Sudanese medicinal plants. BMC Complement Altern Med. 2018 Oct 19;18(1):282. https://doi.org/10.1186/s12906‑018‑2346‑y

22. Selim SA. Chemical composition, antioxidant and antimicrobial activity of the essential oil and methanol extract of the Egyptian lemongrass Cymbopogon proximus Stapf. Grasas Y Aceites. 2011;62(1): 55–61. https://doi.org/10.3989/gya.033810